Other Male Reproductive System O.R. Procedures DRG Reimbursement

DRG 717 encompasses other male reproductive system operating room procedures for non-malignant conditions when a Major Complication or Comorbidity or a Complication or Comorbidity is present, affecting resource intensity and coding assignment. It matters for inpatient reimbursement because proper coding and documentation determine prospective payment classification and hospital payment for higher-acuity surgical encounters.

DRG 717 Overview

DRG 717 covers other male reproductive system operating room procedures for non-malignant conditions when a Major Complication or Comorbidity or a Complication or Comorbidity is present. Typical cases include complex procedures on the prostate, scrotum, testes, or penis that require inpatient surgical care and additional resources due to comorbid conditions or complications. This Diagnosis-Related Group matters for Medicare payment because it groups similar clinical resource use for prospective payment and affects reimbursement levels for hospitals treating these higher-acuity surgical patients. Accurate documentation of diagnoses, procedures, and comorbidities drives correct assignment to this Diagnosis-Related Group.

Trials assessing perioperative management strategies for non-malignant male reproductive surgeries (for example, studies comparing regional versus general anesthesia protocols, or enhanced recovery after surgery bundles) that enroll adult men undergoing procedures such as transurethral resections for benign prostatic hyperplasia, vasovasostomy, or corrective scrotal surgeries. These studies focus on intra- and immediate postoperative complications, pain control, and length of stay, addressing how procedural and anesthetic choices impact short-term morbidity. Findings are directly relevant to clinicians optimizing care pathways and to payers because reductions in complications and hospital days can lower DRG-related costs.
Comparative effectiveness studies of surgical techniques and minimally invasive approaches for benign conditions of the male reproductive tract, enrolling men across age and comorbidity strata to compare outcomes between open, endoscopic, and laparoscopic/robotic procedures. These trials measure functional outcomes (urinary function, fertility implications when applicable), reoperation rates, and resource utilization over 30–90 days to determine which approaches provide the best balance of clinical benefit and cost. Providers use these results to select operative approaches tailored to patient risk, while payers use them to inform coverage and bundled payment policies for procedures captured in this DRG.
Prospective observational and quality-of-life outcomes research following discharge that tracks readmissions, late complications (infection, stricture, chronic pain), return to baseline activities, and patient-reported sexual and urinary function for months to a year after nonmalignant male reproductive O.R. procedures. These studies often include heterogeneous patients with differing CC/MCC profiles to identify predictors of poor post-discharge outcomes and resource use. Results help health systems develop targeted discharge planning and post-acute care interventions and help payers anticipate post-DRG costs associated with readmission risk and long-term functional impairment.

Trials assessing perioperative management strategies for non-malignant male reproductive surgeries (for example, studies comparing regional versus general anesthesia protocols, or enhanced recovery after surgery bundles) that enroll adult men undergoing procedures such as transurethral resections for benign prostatic hyperplasia, vasovasostomy, or corrective scrotal surgeries. These studies focus on intra- and immediate postoperative complications, pain control, and length of stay, addressing how procedural and anesthetic choices impact short-term morbidity. Findings are directly relevant to clinicians optimizing care pathways and to payers because reductions in complications and hospital days can lower DRG-related costs.
Comparative effectiveness studies of surgical techniques and minimally invasive approaches for benign conditions of the male reproductive tract, enrolling men across age and comorbidity strata to compare outcomes between open, endoscopic, and laparoscopic/robotic procedures. These trials measure functional outcomes (urinary function, fertility implications when applicable), reoperation rates, and resource utilization over 30–90 days to determine which approaches provide the best balance of clinical benefit and cost. Providers use these results to select operative approaches tailored to patient risk, while payers use them to inform coverage and bundled payment policies for procedures captured in this DRG.
Prospective observational and quality-of-life outcomes research following discharge that tracks readmissions, late complications (infection, stricture, chronic pain), return to baseline activities, and patient-reported sexual and urinary function for months to a year after nonmalignant male reproductive O.R. procedures. These studies often include heterogeneous patients with differing CC/MCC profiles to identify predictors of poor post-discharge outcomes and resource use. Results help health systems develop targeted discharge planning and post-acute care interventions and help payers anticipate post-DRG costs associated with readmission risk and long-term functional impairment.

OpenPayer

Summary & Overview

Other Male Reproductive System O.R. Procedures Except Malignancy with CC/MCC: Inpatient Reimbursement Overview

DRG 717 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes